RWTN is a hybrid capital security, not common stock.
This listing is a capital note, preference share, or similar instrument associated with Redwood Trust, Inc. 9.125% Seni. Data providers report company-level figures against it, so fundamentals, valuation multiples, and dividend history on this page describe the issuing company, not this instrument, and its market capitalization cannot be computed reliably, so it is not shown. The quoted price is the instrument's own.

Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for RWTN and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for RWTN and 80,000+ other tickers.
See exactly how RWTN's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RWTN and 80,000+ other tickers.
Redwood Trust, Inc. functions as a specialized financial institution throughout the United States. Its operations are divided into three primary areas: Residential Mortgage Banking, Business Purpose Mortgage Banking, and its comprehensive Investment Portfolio. The Residential Mortgage Banking division serves as a pipeline for mortgage loans, acquiring residential debt from third-party originators. These loans are then either sold, securitized, or integrated into its investment holdings. This segment also employs derivative financial instruments to mitigate risks associated with these…
No recent news available.